TechFlow, November 17 — According to Globe Newswire, Sharps Technology (STSS), a U.S.-listed medical device distribution platform and Solana treasury company, released its Q3 2025 financial results, demonstrating strong execution of its Solana-based financial strategy.
The company raised total proceeds of $411 million through PIPE financing, including $267 million in cash and stablecoins and $144 million in SOL tokens. As of October 31, STSS's treasury held over 2 million SOL.
In the third quarter, the company generated approximately $17.7 million in revenue from staking yields and digital asset fair value gains. As of September 30, liquidity in cash and stablecoins was approximately $25.2 million.
Executive Chairman Paul K. Danner stated that adopting a Solana-based financial strategy combined with successful fundraising has created the strongest balance sheet in the company's history. The company has fully exited its legacy syringe manufacturing business and is now focused on two strategic priorities: medical device distribution and maximizing the value of its SOL digital asset treasury.
